{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:26:45Z","timestamp":1780457205549,"version":"3.54.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In association with an update of the Japan Society of Gynecologic Oncology clinical practice guidelines for endometrial cancer in 2023, a systematic review was conducted about the therapeutic benefit of adjuvant therapy on patients with early-stage endometrial carcinoma, who presented positive peritoneal cytology (PPC) without the risk factors for recurrence. The systematic review only included two eligible retrospective studies. Both studies included patients with risk factors for recurrence. A nationwide study in the United States reported that adjuvant chemotherapy was associated with the reduced risk of death among patients with stages I\u2013II endometrial cancer with PPC by multivariate, propensity score-adjusted analysis. Another single-center study in Japan reported no association between adjuvant chemotherapy and relapse-free survival among patients with stage IA endometrial cancer by univariate analysis. This systematic review identified that evidence was limited with conflicting results. Continuous evaluation is warranted to address this clinical question.<\/jats:p>","DOI":"10.1093\/jjco\/hyad140","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T09:18:53Z","timestamp":1697102333000},"page":"217-220","source":"Crossref","is-referenced-by-count":5,"title":["A qualitative systematic review of the significance of adjuvant therapy in patients with low-risk endometrial cancer presenting positive peritoneal cytology: a relevant study to the guideline update for endometrial cancer by the Japan society of gynecologic oncology guideline committee"],"prefix":"10.1093","volume":"54","author":[{"given":"Shogo","family":"Shigeta","sequence":"first","affiliation":[{"name":"Tohoku University School of Medicine Department of Obstetrics and Gynecology, , Sendai , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Konno","sequence":"additional","affiliation":[{"name":"Hokkaido University School of Medicine Department of Obstetrics and Gynecology, , Sapporo , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Terai","sequence":"additional","affiliation":[{"name":"Kobe University Graduate School of Medicine Department of Obstetrics and Gynecology, , Kobe , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Morisada","sequence":"additional","affiliation":[{"name":"Kyorin University Faculty of Medicine Department of Obstetrics and Gynecology, , Mitaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Tohoku University School of Medicine Department of Obstetrics and Gynecology, , Sendai , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Baba","sequence":"additional","affiliation":[{"name":"Iwate Medical University Department of Obstetrics and Gynecology, , Shiwa , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Kyorin University Faculty of Medicine Department of Obstetrics and Gynecology, , Mitaka , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Nagase","sequence":"additional","affiliation":[{"name":"Yamagata University Faculty of Medicine Department of Obstetrics and Gynecology, , Yamagata , Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"2024020717394615700_ref1","author":"Cancer Statistics"},{"key":"2024020717394615700_ref2","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2017.28.e76","article-title":"Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee","volume":"28","author":"Shigeta","year":"2017","journal-title":"J Gynecol Oncol"},{"key":"2024020717394615700_ref3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10147-010-0138-6","article-title":"Evidence-based guidelines for treatment of uterine body neoplasm in Japan: Japan Society of Gynecologic Oncology (JSGO) 2009 edition","volume":"15","author":"Nagase","year":"2010","journal-title":"Int J Clin Oncol"},{"key":"2024020717394615700_ref4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10147-016-0981-1","article-title":"Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms","volume":"21","author":"Ebina","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"2024020717394615700_ref5","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e18","article-title":"Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms","volume":"31","author":"Yamagami","year":"2020","journal-title":"J Gynecol Oncol"},{"key":"2024020717394615700_ref6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijgo.2009.02.010","article-title":"Revised FIGO staging for carcinoma of the endometrium","volume":"105","author":"Creasman","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"2024020717394615700_ref7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"2024020717394615700_ref8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/gyno.2002.6713","article-title":"Assessment of prognostic factors in stage IIIA endometrial cancer","volume":"86","author":"Mariani","year":"2002","journal-title":"Gynecol Oncol"},{"key":"2024020717394615700_ref9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjc.6600698","article-title":"Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus","volume":"88","author":"Kasamatsu","year":"2003","journal-title":"Br J Cancer"},{"key":"2024020717394615700_ref10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/ijgc-00009577-200505000-00016","article-title":"Heterogeneity of stage IIIA endometrial carcinomas: implications for adjuvant therapy","volume":"15","author":"Slomovitz","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"2024020717394615700_ref11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/sj.bjc.6602035","article-title":"Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis","volume":"91","author":"Tebeu","year":"2004","journal-title":"Br J Cancer"},{"key":"2024020717394615700_ref12","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2017.11.601","article-title":"Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database","volume":"218","author":"Seagle","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2024020717394615700_ref13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2018.02.012","article-title":"Significance of abnormal peritoneal cytology on survival of women with stage I\u2013II endometrioid endometrial cancer","volume":"149","author":"Matsuo","year":"2018","journal-title":"Gynecol Oncol"},{"key":"2024020717394615700_ref14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ygyno.2012.09.026","article-title":"Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer","volume":"128","author":"Garg","year":"2013","journal-title":"Gynecol Oncol"},{"key":"2024020717394615700_ref15","author":"Minds Manual Developing Committee","year":"2021"},{"key":"2024020717394615700_ref16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41598-021-03975-5","article-title":"Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer","volume":"12","author":"Kanno","year":"2022","journal-title":"Sci Rep"},{"key":"2024020717394615700_ref17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ijgo.14923","article-title":"FIGO staging of endometrial cancer: 2023","volume":"162","author":"Berek","year":"2023","journal-title":"Int J Gynaecol Obstet"},{"key":"2024020717394615700_ref18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2017.03.011","article-title":"Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer","volume":"145","author":"Scott","year":"2017","journal-title":"Gynecol Oncol"},{"key":"2024020717394615700_ref19","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2019.100514","article-title":"The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas","volume":"44","author":"Wang","year":"2020","journal-title":"Curr Probl Cancer"},{"key":"2024020717394615700_ref20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejca.2020.03.031","article-title":"Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer","volume":"133","author":"Matsuo","year":"2020","journal-title":"Eur J Cancer"},{"key":"2024020717394615700_ref21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/joc.joc_53_22","article-title":"Association of Peritoneal Cytology with other prognostic factors in endometrial cancer","volume":"39","author":"Maricic","year":"2022","journal-title":"J Cytol"},{"key":"2024020717394615700_ref22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/jjco\/hyw063","article-title":"Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis","volume":"46","author":"Lee","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"2024020717394615700_ref23","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"2024020717394615700_ref24","first-page":"CD010681","article-title":"Adjuvant chemotherapy for advanced endometrial cancer","volume":"2014","author":"Galaal","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2024020717394615700_ref25","author":"National Comprehensive Cancer Network (US)","year":"2023"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/54\/2\/217\/56610684\/hyad140.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/article-pdf\/54\/2\/217\/56610684\/hyad140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T17:55:39Z","timestamp":1707328539000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/54\/2\/217\/7307570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,10,11]]},"published-print":{"date-parts":[[2024,2,7]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyad140","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,2]]},"published":{"date-parts":[[2023,10,11]]}}}